| Symbol | RPRX |
|---|---|
| Name | ROYALTY PHARMA PLC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 110 EAST 59TH STREET,FL 33, NEW YORK, New York, 10022, United States |
| Telephone | +1 212 883-0200 |
| Fax | — |
| — | |
| Website | https://www.royaltypharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001802768 |
| Description | Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industrys therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnsons Imbruvica, Astellas and Pfizers Xtandi, Biogens Tysabri, Johnson & Johnsons Tremfya, Gileads Trodelvy, Mercks Januvia, Novartis Promacta, Vertexs Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. Additional info from NASDAQ: |
Hite Christopher 🔴 sold 130.0K shares of Royalty Pharma plc (RPRX) at $57.10 ($7.3M) Transaction Date: Jun 30, 2026 | Filing ID: 000011
Read more📋 SCH Investment Partners LLC (Officer) plans to sell 100K shares of Royalty Pharma PLC (at $57.09 each, total $5.7M) Filed: Jun 30, 2026 | ID: 046352
Read moreDirector Bassler Bonnie L 🟢 acquired 689 shares of Royalty Pharma plc (RPRX) at $54.40 Transaction Date: Jun 30, 2026 | Filing ID: 000014
Read moreUrist Marshall 🔴 sold 9.1K shares of Royalty Pharma plc (RPRX) at $55.18 Transaction Date: Jun 24, 2026 | Filing ID: 000020
Read moreHite Christopher 🔴 sold 150.0K shares of Royalty Pharma plc (RPRX) at $54.47 ($8.2M) Transaction Date: Jun 23, 2026 | Filing ID: 000009
Read more📋 Urist Marshall (Officer) plans to sell 9K shares of Royalty Pharma plc (at $55.18 each, total $502K) Filed: Jun 24, 2026 | ID: 000296
Read more📋 Christopher Hite (Officer) plans to sell 30K shares of Royalty Pharma PLC (at $55.35 each, total $1.7M) Filed: Jun 23, 2026 | ID: 044949
Read more📋 SCH Investment Partners LLC (Officer) plans to sell 150K shares of Royalty Pharma PLC (at $54.45 each, total $8.2M) Filed: Jun 23, 2026 | ID: 044947
Read moreNew Form SCHEDULE 13D/A - Royalty Pharma plc <b>Filed:</b> 2026-06-16 <b>AccNo:</b> 0001140361-26-025447 <b>Size:</b> 35 KB
Read moreDirector WEATHERMAN ELIZABETH H 🟢 acquired 4.5K shares of Royalty Pharma plc (RPRX) Transaction Date: Jun 05, 2026 | Filing ID: 000003
Read more